CompaniesAlere Medical, Inc. (Acquired)
At the time of Cutlass Capital's initial investment, Alere was an expansion stage specialty health care services company providing outsourced disease management services for patients with chronic diseases. The company was sold to TA Associates in April 2007.
At the time of Cutlass Capital's initial investment, Apneon was an early stage medical device company developing proprietary devices for the treatment of sleep apnea. The company was sold in January 2009.
Byram Holdings, Inc. (Acquired)
At the time of Cutlass Capital's initial investment, Byram was a late stage health care distribution company providing a full range of home health care products to patients in their homes. The company was sold to OPG in March 2008.
CardioKinetix is an early stage medical device company developing proprietary devices for the treatment of heart failure.
At the time of Cutlass Capital's initial investment, Evalve was an early stage medical device company seeking to revolutionize the treatment of mitral valve disease with a minimally invasive approach. The company was sold to Abbott in November 2009.
GI Dynamics is an early stage medical device company developing proprietary devices for the treatment of obesity and Type 2 diabetes.
Hemosphere is a commercial stage medical device company developing innovative vascular access products for hemodialysis.
IntelliCare America, Inc. (Acquired)
At the time of Cutlass Capital's initial investment, IntelliCare was an expansion stage specialty health care services and application software company providing medical contact center outsourcing services and technology products. The company was sold to PolyMedica, Inc. on October 2005.
Titan is an expansion stage specialty health care services company that serves as a partner to physicians in the building, financing, and management of specialty ambulatory surgery centers.
TranS1 is a commercial stage medical device company seeking to revolutionize the surgical treatment of the spine with a minimally invasive approach. The company completed its IPO and began trading on the NASDAQ under the ticker symbol TSON in October 2007.
Xoft is a commercial stage medical device company which has developed a minituarized x-ray tube for the treatment of a variety of different cancer.